PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
1-Year Return
3.82%
This Quarter Return
+13.06%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$16.6M
AUM Growth
+$2.94M
(+21%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-7,238.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
4
Reduced
2
Closed
1
Top Buys
| 1 |
CAI
Caris Life Sciences, Inc. Common Stock
CAI
|
+$2.4M |
| 2 |
Outset Medical
OM
|
+$1.34M |
| 3 |
Establishment Labs
ESTA
|
+$960K |
| 4 |
Natera
NTRA
|
+$418K |
| 5 |
Metagenomi
MGX
|
+$283K |
Top Sells
| 1 |
BBNX
Beta Bionics, Inc. Common Stock
BBNX
|
+$1.07B |
| 2 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
+$142M |
| 3 |
KMTS
Kestra Medical Technologies, Ltd. Common Stock
KMTS
|
+$997K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBNX
1
Beta Bionics, Inc. Common Stock
BBNX
$1.15B
| $6.25M | 37.57% |
2,500
-426,620
| -99% | -$1.07B |
|
|
IMDX
2
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$88.1M
| $2.86M | 17.2% |
18,700
-928,434
| -98% | -$142M |
|
|
CAI
3
Caris Life Sciences, Inc. Common Stock
CAI
$9.58B
| $2.4M | 14.45% |
+45,000
| New | +$2.4M |
|
|
4
Establishment Labs
ESTA
$1.09B
| $1.92M | 11.56% |
89,940
+44,940
| +100% | +$960K |
|
|
5
Outset Medical
OM
$243M
| $1.36M | 8.18% |
429,120
+424,120
| +8,482% | +$1.34M |
|
6
InspireMD
NSPR
$99.3M
| $1.02M | 6.15% |
450,517
| – | – |
|
|
7
Natera
NTRA
$23.1B
| $422K | 2.54% |
245,691
+243,191
| +9,728% | +$418K |
|
|
8
Metagenomi
MGX
$69.8M
| $391K | 2.35% |
952,134
+687,743
| +260% | +$283K |
|
|
KMTS
9
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$1.12B
| – | – |
-40,000
| Closed | -$997K |
|